Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: Helical CT and MR imaging findings with clinical-pathologic comparison

Radiology

Volumn 243, Issue 2, 2007, Pages 422-430

  Iannaccone, Riccardo ^a,c,e   Piacentini, Francesca ^a,b   Murakami, Takamichi ^d   Paradis, Valérie ^a   Belghiti, Jacques ^a   Hori, Masatoshi ^d   Kim, Tonsok ^d   Durand, François ^a   Wakasa, Kenichi ^d   Monden, Morito ^d   Nakamura, Hironobu ^d   Passariello, Roberto ^c   Vilgrain, Valérie ^a  

^a BEAUJON HOSPITAL   (France)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d OSAKA UNIVERSITY   (Japan)

^e NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; GADOLINIUM CHELATE; NONIONIC CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HEPATIC ARTERY; HUMAN; HYPERTENSION; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MALE; MORPHOLOGY; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TUMOR DIFFERENTIATION; TUMOR NECROSIS; TUMOR VOLUME;

ALCOHOLISM; CARCINOMA, HEPATOCELLULAR; FATTY LIVER; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 34247482247     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2432051244     Document Type: Article

References (46)

1. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999;353:1253-1257.
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.
3. Clark JM, Diehl AM. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 2003;289:3000-3004.
4. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis 2004;24:3-20.
5. Sanyal AJ: American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002;123:1705-1725.
6. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994;107:1103-1109.
7. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450-455.
8. Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000;32:689-692.
9. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664-669.
10. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134-140.
11. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419.
12. Ong J, Younossi ZM, Reddy V, et al. Cryptogenic cirrhosis and posttransplantation non-alcoholic fatty liver disease. Liver Transpl 2001;7:797-801.
13. Orikasa H, Ohyama R, Tsuka N, Eyden BP, Yamazaki K. Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus. J Submicrosc Cytol Pathol 2001;33:195-200.
14. Mori S, Yamasaki T, Sakaida I, et al. Hepatocellular carcinoma with nonalcoholic steatohepatitis. J Gastroenterol 2004;39:391-396.
15. Cotrim HP, Parana R, Braga E, Lyra L. Non-alcoholic steatohepatitis and hepatocellular carcinoma: natural history? Am J Gastroenterol 2000;95:3018-3019.
16. Zen Y, Katayanagi K, Tsuneyama K, Harada K, Araki I, Nakanuma Y. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int 2001;51:127-131.
17. Shimada M, Hashimoto E, Taniai M, et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002;37:154-160.
18. Ratziu V, Bonyhay L, Di Martino V, et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002;35:1483-1493.
19. Ong JP, Younossi ZM. Is hepatocellular carcinoma part of the natural history of non-alcoholic steatohepatitis? Gastroenterology 2002;123:375-378.
20. Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989;20: 594-598.
21. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80.
22. Bullock RE, Zaitoun AM, Aithal GP, Ryder SD, Beckingham IJ, Lobo DN. Association of non-alcoholic steatohepatitis without, significant fibrosis with hepatocellular carcinoma. J Hepatol 2004;41:685-686.
23. Anagnostopoulos GK, Arvanitidis D, Tsiakos S, Margantinis G, Grigoriadis K, Kostoponlos P. Is hepatocellular carcinoma part of the natural history of non-alcoholic steatohepatitis? J Clin Gastroenterol 2003;37:88-89.
24. Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002;36:1349-1354.
25. Hashimoto E, Taniai M, Kaneda H, et al. Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis. Alcohol Clin Exp Res 2004;28(8 suppl proceedings):164S-168S.
26. Cuadrado A, Orive A, Garcia-Suarez C, et al. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma. Obes Surg 2005; 15:442-446.
27. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med 1998;15: 339-553.
28. Brancatelli G, Federle MP, Grazioli L, Carr BI. Hepatocellular carcinoma in noncirrhotic liver: CT, clinical, and pathologic findings in 39 U.S. residents. Radiology 2002;222:89-94.
29. Lafortune M, Matricardi L, Denys A, Favret M, Dery R, Pomier-Layrargues G. Segment 4 (the quadrate lobe): abarometer of cirrhotic liver disease at US. Radiology 1998;206: 157-160.
30. Ishak KG, Anthony PP, Solin LH. Histological typing of tumors of the liver. 2nd ed. Berlin, Germany: Springer, 1994; 20.
31. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48900 necropsies. Cancer 1954;7:462-503.
32. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999; 19:271-285.
33. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460-468.
34. Nair S, Verma S, Thuluvath PJ. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology 2002;35:105-109.
35. Daniele B, Bencivenga A, Megna AS, Tinessa V. Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 2004;127(5 suppl 1):S108-S112.
36. Schwartz M. Liver transplantation for hepatocellular carcinoma. Gastroenterology 2004;127(5 suppl 1):S268-S276. [Published correction appears in Gastroenterology 2005;128:523.]
37. Ng IO, Lai EC, Ng MM, Fan ST. Tumor encapsulation in hepatocellular carcinoma: a pathologic study of 189 cases. Cancer 1992; 70:45-49.
38. Luca A, Vizzini G, Miraglia R, et al. Predictive factors of massive tumor necrosis induced by transcatheter arterial treatment in patients with hepatocellular carcinoma (HCC): a multivariate analysis of CT findings before treatment. Presented at the 103rd Meeting of the American Roentgen Ray Society, San Diego, Calif, May 4-9, 2003.
39. Taouli B, Losada M, Holland A, Krinsky G. Magnetic resonance imaging of hepatocellular carcinoma. Gastroenterology 2004;127(5 suppl 1):S144-S152.
40. Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995;22:1714-1719.
41. Saadeh S, Younossi ZM, Reiner EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:745-750.
42. Smalley SR, Moertel CG, Hilton JF, et al. Hepatoma in the noncirrhotic liver. Cancer 1988;62:1414-1424.
43. Nzeako UC, Goodman ZD, Ishak KG. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers: a clinico-histopathologic study of 804 North American patients. Am J Clin Pathol 1996;105:65-75.
44. Bismuth H, Chiche L, Castaing D. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg 1995;19:35-41.
45. Winston CB, Schwartz LH, Fong Y, Blumgart LH, Panicek DM. Hepatocellular carcinoma: MR imaging findings in cirrhotic livers and noncirrhotic livers. Radiology 1999;210:75-79.
46. Bralet MP, Regimbeau JM, Pineau P, et al. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology 2000;32:200-204.